Kebede Sewnet Adem, Tusa Biruk Shalmeno, Weldesenbet Adisu Birhanu
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Epidemiology and Biostatistics, College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.
Anemia. 2021 Feb 10;2021:6627979. doi: 10.1155/2021/6627979. eCollection 2021.
Anaemia is one of the commonest blood disorders seen in patients with diabetes. In Ethiopia, chronic illnesses are tremendously raising with their complications. But very little research has been conducted, particularly on anaemia among diabetes mellitus (DM) patients. Therefore, this study aimed at assessing the prevalence of anaemia and associated factors among type 2 diabetes mellitus patients in Northwest Ethiopia.
A cross-sectional study design was employed at University of Gondar Comprehensive Specialized Hospital from March 1 to April 15, 2019, among 372 type 2 diabetes mellitus patients (T2DM). Multivariable logistic regression analysis was fitted, and the corresponding adjusted odds ratio (AOR) and 95% CI were used to identify factors associated with anaemia. Level of significance was declared at the value less than 0.05.
The study revealed 8.06% (95% CI: 5.68-11.31%) of the participants were anaemic. Being male (AOR = 2.74, CI: 1.02, 7.38), combined type of treatment (AOR = 8.38, CI: 1.66, 42.25), having diabetes-related microvascular complications (AOR = 3.24, CI: 1.14, 9.26), and hypertension (AOR = 0.01, CI: 0.002, 0.06) were the significant factors associated with anaemia.
The finding of the current study revealed low prevalence of anaemia among T2DM patients. Sex, type of treatment, diabetes-related microvascular complications, and hypertension were factors associated with anaemia. Assessment of haemoglobin levels among T2DM patients may help to prevent ensuing microvascular complications. Incorporate anaemia screening into the routine assessment of diabetic complication particularly for those who are hypertensive and took combined treatment to allow early appreciation and treatment of anaemia and later improve the overall care of patients with diabetes.
贫血是糖尿病患者中最常见的血液疾病之一。在埃塞俄比亚，慢性病及其并发症的发生率正在大幅上升。但相关研究极少，尤其是关于糖尿病（DM）患者贫血情况的研究。因此，本研究旨在评估埃塞俄比亚西北部2型糖尿病患者贫血的患病率及相关因素。
2019年3月1日至4月15日，在贡德尔大学综合专科医院对372例2型糖尿病患者（T2DM）采用横断面研究设计。进行多变量逻辑回归分析，并使用相应的调整优势比（AOR）和95%置信区间（CI）来确定与贫血相关的因素。显著性水平设定为p值小于0.05。
研究显示8.06%（95%CI：5.68 - 11.31%）的参与者患有贫血。男性（AOR = 2.74，CI：1.02，7.38）、联合治疗类型（AOR = 8.38，CI：1.66，42.25）、患有糖尿病相关微血管并发症（AOR = 3.24，CI：1.14，9.26）以及高血压（AOR = 0.01，CI：0.002，0.06）是与贫血相关的显著因素。
本研究结果显示T2DM患者贫血患病率较低。性别、治疗类型、糖尿病相关微血管并发症和高血压是与贫血相关的因素。评估T2DM患者的血红蛋白水平可能有助于预防随之而来的微血管并发症。将贫血筛查纳入糖尿病并发症的常规评估中，特别是对于那些患有高血压且接受联合治疗的患者，以便早期识别和治疗贫血，进而改善糖尿病患者的整体护理。
